Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680040 · ClinicalTrials.gov registry record
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
A clinical trial, sponsored by Edwards Lifesciences.
- Terminated
- Registry status
- 110
- Enrollment target
NCT03680040 is a clinical trial that was terminated before completion, run by Edwards Lifesciences. The registered enrollment target is 110 participants.
The verdict
NCT03680040 was terminated before completion, sponsored by Edwards Lifesciences.
- TERMINATED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.
Interventions
- DIAGNOSTIC_TEST Subjects previously implanted with a RESILIA aortic tissue valve.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2024-02-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03680040
The ClinicalTrials.gov registry entry for NCT03680040 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Subjects previously implanted with a RESILIA aortic tissue valve. is the first listed.
NCT03680040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03680040 about?
NCT03680040 is a clinical study titled "RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65". The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.
What is the current status of trial NCT03680040?
This trial is currently terminated. The enrollment target is 110 participants. The study started on 2018-11-05. Estimated completion is 2024-02-13.
What interventions are being tested in trial NCT03680040?
The interventions under investigation include: Subjects previously implanted with a RESILIA aortic tissue valve. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03680040?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.